Jury Awards $37 Million in Asbestos-Laden Talc Baby Powder Lawsuit
A New Jersey couple has been awarded a $37 million verdict against J&J and its supplier Imerys Talc America for the talc powder that caused
Read MorePhilippine FDA Issues Talc Powder Advisory
The Food and Drug Administration for the Philippines has issued an advisory regarding the use of talc in cosmetic products in Southeast Asian nations. The
Read MoreJohnson & Johnson Facing More Invokana Lawsuits
Johnson & Johnson and its subsidiary Janssen Pharmaceuticals are facing mounting lawsuits after new evidence has demonstrated that Invokana, the popular diabetes drug, has been
Read MoreFBI Probing Witness Tampering in DePuy Hip Cases
A federal judge in Texas has ordered the FBI to investigate DePuy concerning witness tampering allegations concerning the bellwether DePuy hip implant lawsuit cases.
Read MoreVerdict Upheld in Risperdal Case Against Janssen Pharmaceutical
A $2.5 million verdict in the first Risperdal case to go to jury related to the condition gynecomastia has been upheld, after a judge in
Read MoreLos Angeles Jury Awards Talc Powder Victim $417 Million
In the largest verdict thus far in talc powder lawsuits, a Los Angeles jury has awarded a 63-year-old woman $417 million, finding the manufacturer of
Read MoreMulti-Million Dollar Verdict in Ethicon Vaginal Mesh Lawsuit
Johnson & Johnson has again been ordered to pay out millions to a woman who suffered serious injuries after being implanted with one of their
Read MoreAs Xarelto Trial Begins, Manufacturers Deny Drug’s Risks
As the first Xarelto bellwether trial began last week in New Orleans, drug manufacturers Johnson & Johnson and Bayer were on the defensive attempting to
Read MoreInvokana Among Drugs Under FDA Investigation for Potential Link to Acute Pancreatitis
The Food and Drug Administration has launched an investigation into a class of drugs used to treat diabetes. The class of drugs are known as
Read MoreUS Hospitals Fail to Report Power Morcellator Surgery Complications
In October 2016 federal regulators announced that 12 U.S. hospitals, including well-known medical centers in Los Angeles, Boston and New York, failed to promptly report
Read More